Smruthy Sivakumar - Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA

David M Walter, Katherine Cho,Smruthy Sivakumar, Iris T-H Lee, Anders B Dohlman, Ethan Shurberg, Kevin X Jiang, Akansha A Gupta,Garrett M Frampton,Matthew Meyerson

bioRxiv the preprint server for biology (2025)

Cited0Views0WOSBibtex

Tissue-based Genomic Profiling of 300,000 Tumors Highlights the Detection of Variants with Low Allele Fraction

Saumya D Sisoudiya,Hanna Tukachinsky, Rachel B Keller-Evans, Alexa B Schrock,Richard S P Huang,Ole Gjoerup,Michael J Pishvaian,Rachna Shroff,Ethan S Sokol,Lucas Dennis,Garrett M Frampton,Smruthy Sivakumar

NPJ precision oncologyno. 1 (2025): 190-190

Cited0Views0WOSBibtex

Impact of HER2 Low Status on Genomic Signatures in Triple Negative Breast Cancer (TNBC)

Melissa Taylor,Shilpa Reddy,Prashanth Ashok Kumar,Dana Hariri,Ethan Sokol,Smruthy Sivakumar,Julia Quintanilha,Dean Pavlick,Mia Alyce Levy,Jeffrey S. Ross,Maryam B. Lustberg

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Novel Potential Mechanisms of Acquired Resistance to Anti-Egfr Monoclonal Antibody (mab) Therapy Detected in Liquid Biopsies (lbx) from Patients (pts) with Advanced Colorectal Cancer (CRC)

Christine Megerdichian Parseghian,Jessica Kim Lee,Julia Quintanilha,Alexa B. Schrock,Ryon Graf,Lincoln Pasquina,Smruthy Sivakumar,Geoffrey R. Oxnard,Hanna Tukachinsky,Samuel J. Klempner,Scott Kopetz

Journal of Clinical Oncologyno. 3_suppl (2024): 199-199

Cited0Views0Bibtex

Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors

Yoonha Choi,Neekesh V. Dharia,Tomi Jun,Julie Chang,Stephanie Royer-Joo,Kenneth K. Yau,Zoe J. Assaf,Junko Aimi,Smruthy Sivakumar,Meagan Montesion,Adrian Sacher,Patricia LoRusso,Jayesh Desai,Jennifer L. Schutzman,Zhen Shi

CLINICAL CANCER RESEARCHno. 17 (2024): 3788-3797

Cited0Views0WOSBibtex

GO42144 INVESTIGATORS AND STUDY GROUP1 from Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn